Sun to acquire Daiichi's 11.28% stake in Zenotech

The primary objective of the transaction from acquirer's perspective is to consolidate its holding in the target company, the Mumbai-based drug firm said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/OMjUp2P
via IFTTT